(Press-News.org) Minocycline, an older, broad-spectrum antibiotic in the tetracycline family, provides meaningful improvements as a therapeutic for children with fragile X syndrome, a study by researchers at the UC Davis MIND Institute has found. The finding is important, the researchers said, because minocycline is a targeted treatment for the condition that is readily available by prescription.
After three months of treatment with minocycline, children with fragile X syndrome had greater improvements in general behavior, anxiety and mood-related behaviors when compared with children with fragile X syndrome who received placebo rather than the medication. The study was led by Mary Jacena Leigh, associate clinical professor of behavioral and developmental pediatrics with the Fragile X Treatment and Research Center at the MIND Institute.
"This study provides evidence of the efficacy of this medication as targeted treatment for fragile X syndrome with a long history of use and that can currently be prescribed," Leigh said. "Further studies examining the long-term benefits and side effects are needed, perhaps in combination with other educational and medication treatments currently being developed for individuals with the condition."
The research is published online today in the Journal of Developmental and Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Fragile X syndrome is the most common inherited cause of intellectual impairment, formerly termed mental retardation, and is the leading known single-gene cause of autism spectrum disorder. The United States Centers for Disease Control and Prevention (CDC) estimates that about 1 in 4,000 males and females have the disorder. The condition is caused by a mutation in a single gene, FMR1, found on the X chromosome.
For the current study, 66 children with fragile X syndrome were randomly assigned to three months of treatment with minocycline or an inactive placebo. After three months, the study participants were switched to the other treatment. Parents and doctors did not know which treatment the child received until completion of the study.
Fifty-five patients completed the study. The children had small but significant improvements in certain areas during treatment with minocycline, compared to placebo. In particular, they scored better on the Clinical Global Impression Scale, on which doctors and parents rated their overall impression of the patients' status.
Children taking minocycline also had greater improvement in anxiety and mood-related behaviors, as rated by parents. Other outcomes were not significantly better with minocycline, including behavior problems and verbal functioning.
Side effects were generally similar between groups, with no serious adverse effects. Minocycline may cause some discoloration of the teeth — a known side effect of minocycline and related antibiotics — which was seen in both treatment arms.
"Some children responded very well to minocycline; others did not, so we now are studying biomarkers that can help us determine who will be a responder," said Randi Hagerman, MIND Institute medical director and the study's senior author.
Minocycline is an older antibiotic and most commonly is used for treatment of severe acne. Studies in animal models and initial studies in humans have suggested that it might have beneficial effects in the treatment of fragile X. It also has been studied as a potential "neuroprotective" treatment for other conditions, such as multiple sclerosis.
Other treatments for the condition now under investigation include a class of drugs called mGluR5 agonists and GABA agonists, such as ganaxolone or arbaclofen, which also are studied at the MIND Institute. However, minocycline is the only targeted fragile X treatment currently available by prescription. Because of its long history of use, the side effects and safety characteristics of minocycline are well known.
###
Other study authors include Danh V. Nguyen, Yi Mu, Andrea Schneider, Tasleem Checki, Jonathan Polussa, Paul Doucet, Flora Tassone, Susan M. Rivera, David Hessl, and Randi J. Hagerman, all of UC Davis and Tri Indah Winarni of Diponegoro University, Indonesia.
The study was funded by the National Fragile X Foundation, grant UL1 TR000002 from the National Center for Advancing Translational Sciences (Nguyen), Interdisciplinary Training for Autism Researchers 5T32MH073124 (Leigh), A Toolbox of Outcome Measures for Targeted Treatment Trials in Children 3UL1 RR024146-04S4, and the Fragile X Research Center Grant HD02274. END
HOUSTON – (April 8, 2013) – Is the era of targeted therapy for breast cancer at hand? It could be, said experts at the Lester and Sue Smith Breast Center at Baylor College of Medicine – at least for a certain population of women.
In a report that appears online today in the Journal of Clinical Oncology, the researchers have shown that a subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of targeted treatments that zero in on the breast cancer cells ...
Washington, D.C.— Carnegie scientists have found that the plant species making up an ecosystem are better predictors of ecosystem chemistry than environmental conditions such as terrain, geology, or altitude. This is the first study using a new, high-resolution airborne, chemical-detecting instrument to map multiple ecosystem chemicals. The result, published in the April 8, 2013, Early Edition of the Proceedings of the National Academy of Sciences, is a key step toward understanding how species composition affects carbon, nitrogen and other nutrient cycling, and the effects ...
Cancer survivors who had chest radiation are nearly twice as likely to die in the years after having major heart surgery as similar patients who didn't have radiation, according to research in the American Heart Association journal Circulation.
Chest radiation to kill or shrink breast cancer, Hodgkin's lymphoma and other cancers increases survivors' risk for major heart disease years — even decades — after radiation therapy.
"While radiation treatments done on children and adults in the late 1960s, '70s and '80s played an important role in cancer survival, the treatment ...
Albert Einstein famously described quantum entanglement as "spooky action at distance"; however, up until now experiments that examine this peculiar aspect of physics have been limited to relatively small distances on Earth.
In a new study published today, 9 April, in the Institute of Physics and German Physical Society's New Journal of Physics, researchers have proposed using the International Space Station (ISS) to test the limits of this "spooky action" and potentially help to develop the first global quantum communication network.
Their plans include a so-called ...
Philadelphia, Pa. (April 8, 2012) – The antibiotic drug minocycline yields "modest" but meaningful improvements in functioning and mood for children with fragile X syndrome (FXS), reports a study in the April Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Three months of treatment with minocycline in children with FXS resulted in greater overall improvement than placebo treatment, according to ...
Monarch butterflies have long been admired for their sense of direction, as they migrate from Canada and the United States to Mexico. According to new findings from a team of scientists, including researchers from the University of Guelph, the winged insects fly without a map, and use basic orientation and landmarks to find their way to their wintering sites, thousands of miles away.
Recently published in the Proceedings of the National Academy of Sciences USA, the study examined the insects' flight patterns and whether those patterns changed when the butterflies were ...
Intrauterine devices (IUDs) are as safe for teenagers – including those who have never given birth – as they are for adults, according to research from the University of Texas Medical Branch at Galveston.
Published in the May issue of Obstetrics & Gynecology, the findings disprove concerns that have persisted for more than 30 years, since the removal of a harmful IUD from the market in the 1970's, and open the door for many more women – teens included – to benefit from the highly effective, long-lasting form of contraception.
"Today's IUDs are not the same as the ones ...
SEATTLE – Although previous research has linked alcohol consumption to an increased risk of developing breast cancer, a new study has found that drinking before and after diagnosis does not impact survival from the disease. In fact, a modest survival benefit was found in women who were moderate drinkers before and after diagnosis due to a reduced risk of dying from cardiovascular disease, a major cause of mortality among breast cancer survivors.
The study results will be published in the April 8 edition of the Journal of Clinical Oncology. Polly Newcomb, Ph.D., a member ...
Health systems worldwide are increasingly negotiating secret price rebates from pharmaceutical companies and Canadians risk losing out on the deal.
"The pricing of medicines is now a game of negotiation, similar to buying a car at a dealership," says Steve Morgan, an expert in health policy at the University of British Columbia. "There's a list price equivalent to a manufacturer's suggested retail price; and then there's secret deals that everyone negotiates from there."
In a study published today in the April issue of the journal Health Affairs, researchers interviewed ...
A study suggests that states with stricter school meal nutrition standards were associated with better weight status among students who received free or reduced-price lunches compared with students who did not eat school lunches, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
The National School Lunch Program (NSLP) was started in 1946 to improve student nutrition by providing school lunches according to standards sets by the U.S. Department of Agriculture (USDA). However, the program has faced criticism that the lunches did ...
